期刊文献+

新风胶囊治疗活动期类风湿性关节炎20例 被引量:13

Treatment of 20 Cases of Rheumatoid Arthritis in Active Stage with Xinfeng Capsule
暂未订购
导出
摘要 目的 :观察健脾化湿通络中药新风胶囊 (XFC)治疗活动期类风湿性关节炎 (RA)的临床疗效 ,并探讨其作用机制。方法 :4 0例活动期RA患者随机分为 2组 ,治疗组 2 0例采用XFC ,对照组 2 0例采用雷公藤多苷片 ,两组均以 3个月为 1个疗程 ,均治疗 1个疗程 ,观察临床疗效及C反应蛋白、类风湿因子、CD4 + 、CD8+ 、CD4 + /CD8+ 、细胞因子 (IL 1、TNFα、IL 4、IL 10 )及血管内皮生长因子 (VEGF)等指标的变化。结果 :XFC在总有效率、改善活动期RA关节症状及部分实验室指标方面与雷公藤多苷片作用相似 ,但在改善全身症状及治疗脾虚湿盛、血瘀证候 ,调节CD4 + /CD8+ ,调整细胞因子平衡及降低VEGF方面显著优于雷公藤多苷片 ;而且XFC药物不良反应 (如食欲减退、腹胀、腹泻 )的积分值显著低于对照组。结论 :XFC可综合改善活动期RA的关节及全身病变 ,无不良反应 ,其作用机制是调节T细胞免疫功能 ,下调致炎因子 ,上调抑炎因子 ,降低血管通透性 ,抑制血管增生 。 Objective:To observe the clinical effects of Xinfeng capsule (XFC), a traditional Chinese prescription for invigorating the spleen Qi, removing dampness and obstruction in the channels, in treating rheumatoid arthritis (RA) in active stage, and explore the mechanism. Method: 40 cases of RA were randomly divided into two groups. The treatment group (n=20) was treated with XFC for three months as a therapeutic course, and the control group (n=20) with tripterygium wilfordii polycoside tablet (TPT) for three months as a therapeutic course. Two groups were all treated for one course. The targets including clinical effects, C reactive protein, rheumatoid factor, CD4 +, CD8 +, CD4 +/CD8 + ratio, cytokin(CK), vascular endothelial growth factor (VEGF) were observed. Result: The effects of XFC were similar to that of TPT in the total effective rate, improving the joint symptoms, et al. But the XFC was superior to TPT in improving general symptoms of the patients with RA, regulating CD4 +/ CD8 + ratio and CK and reducing VEGF. The integrals of side effects such as poor appetite, abdominal distention and diarrhea in XFC group were lower than those in TPT group. Conclusion: XFC is able to improve the joint and general symptoms in the patients with RA in active stage, and has no side effects. The mechanism may relate to regulating the function of T lymphocyte, down regulating interleukin 1, tumor necrosis factor α and up regulating interleukin 4, interleukin 10, restraining the hyperplasia of blood vessel, reducing the permeability of blood vessel, improving the microcirculation and protecting the gastric mucosa.
出处 《安徽中医学院学报》 CAS 2003年第3期12-16,共5页 Journal of Anhui Traditional Chinese Medical College
基金 国家卫生部优秀青年科技基金资助项目 (992 6 )
关键词 活动期类风湿性关节炎 新风胶囊 治疗 中医药疗法 Rheumatoid arthritis Xinfeng capsule Tripterygium wilfordii polycoside tablet Immune function Cytokin Vascular endothelial growth factor
  • 相关文献

参考文献11

  • 1刘健.韩明向教授治疗历节病学术经验[J].安徽中医学院学报,1999,18(5):45-47. 被引量:24
  • 2刘健.健脾化湿通络法治疗历节病45例临床研究[J].安徽中医临床杂志,1999,11(6):380-382. 被引量:25
  • 3郭虎占 董泽宏 等.中药现代研究与应用(第5卷)[M].北京:学苑出版社,1998.4492-4506.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则(第一辑)[M].,1993.91.
  • 5王天,刘复强,唐福林,吴轶苹,叶进,崔晶,杨磊,杨光燃.类风湿关节炎患者血管内皮生长因子的测定[J].中华风湿病学杂志,2002,6(6):448-450. 被引量:3
  • 6..中药新药临床研究指导原则(第一辑)[S].中华人民共和国卫生部,1993.91..
  • 7Arnett FC, Edworthy SM, Bloch DA, et al. The 1987 revised ARA criteria for rheumatoid arthritis (RA) [J ].Arthritis Rheum, 1987, 30(Suppl 17):45.
  • 8Joosten LAB. Lubberts E, Durez P, et al . Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis[J]. Arthritis Rheumatism, 1989, 40(2) :249.
  • 9Wilckens T, Rijk RK. Glucocorticoids and immune function: Unknown dimensions and new frontes [J]. Immunl Today, 1997, 4(8) :23.
  • 10Walmsley M, Katskis PD, Abnney E, et al . Interlukin- 10 inhibition of established collagen-induced arthritis [J ].Arthritis Rheumatism, 1996, 39(7) :495.

二级参考文献6

  • 1Koch AE,Harlow LA,Haine GK,et al.Vascular endothelial growth factor:a cytokine modulating endothelial function in rheumatoid arthritis.J Immunol,1994,4:4149-4156.
  • 2Kikuchi K,Kubo M,Kadono T,et al.Serum concentration of vascular endothelial growth factor in collagen diseases.Br J Dermatol,1998,139:1049-1051.
  • 3Paleolog EM,Young S,Stark AC,et al.Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis.Arthritis Rheum,1998,41:1258-1265.
  • 4Sone H,Sakauchi M,Takahashi A,et al.Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity.Life Sci,2001,69:1861-1869.
  • 5Lee SS,Joo YS,Kim WU,et al.Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.Clin Exp Rheumatol,2001,19:321-324.
  • 6Harada M,Mitsuyama K,Yoshida H,et al.Vascular endothelial growth factor in patients with rheumatoid arthritis.Scand J Rheumatol,1998,27:377-380.

共引文献46

同被引文献238

引证文献13

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部